All recalls
Every recall from CPSC, FDA, USDA and NHTSA, newest first. Each one links to the agency's official notice. Looking for one product? Check a product.
2,237 recalls ยท page 22 of 45
-
Class IIofficial
GenoGenix LLC recalls BPC-157/Thymosin Beta-4 for InjectionLack of Assurance of Sterility
-
Class IIofficial
GenoGenix LLC recalls Thymosin Beta-4 (TB4) for InjectionLack of Assurance of Sterility
-
Class IIofficial
GenoGenix LLC recalls Tesamorelin for InjectionLack of Assurance of Sterility
-
Class IIofficial
GenoGenix LLC recalls Epithalon for InjectionLack of Assurance of Sterility
-
Class IIofficial
GenoGenix LLC recalls Sermorelin Lyophilized powder for reconstitutionLack of Assurance of Sterility
-
Class IIofficial
GenoGenix LLC recalls Semaglutide for InjectionLack of Assurance of Sterility
-
Class IIofficial
GenoGenix LLC recalls TirzepatideLack of Assurance of Sterility
-
Class IIofficial
GenoGenix LLC recalls Retatrutide for InjectionLack of Assurance of Sterility
-
Class Iofficial
GenoGenix LLC recalls NAD+ (Nicotinamide adenine dinucleotide) for InjectionMicrobial Contamination of Sterile Products: elevated endotoxin levels
-
Class IIofficial
Cardinal Health Inc. recalls Xolair (omalizumab injection)CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.
-
Class IIofficial
Cardinal Health Inc. recalls Xolair (omalizumab injection)CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.
-
Class IIofficial
Cardinal Health Inc. recalls RECOMBINATECGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.
-
Class IIofficial
Exela Pharma Sciences LLC recalls 4.2% Sodium Bicarbonate InjectionFailed Impurities/Degradation Specifications: out of specification results for arsenic in the impurities tested.
-
Class IIofficial
Pfizer recalls Levoxyl (levothyroxine sodium tabletsSubpotent drug
-
Class IIofficial
Amerisource Health Services LLC recalls Sucralfate TabletsCGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.
-
Class IIofficial
Alembic Pharmaceuticals Limited recalls Doxepin Hydrochloride CapsulesCGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
-
Class IIofficial
Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
-
Class IIIofficial
Cipla USA, Inc. recalls Albuterol SulfateFailed Stability Specifications: Out of specification results was observed in Induction Port during the analysis of Particle size distribution at the 12-month time point.
-
Class IIofficial
Hikma Pharmaceuticals USA Inc. recalls Lorazepam InjectionFailed Impurities/Degradation Specifications: An out-of-Specification for total related compounds
-
Class IIofficial
Taizhou Kangping Medical Science And Technology Co., Ltd. recalls BZK Antiseptic ToweletteLack of Assurance of Sterility.
-
Class IIofficial
Ascend Laboratories, LLC recalls Amlodipine and Olmesartan Medoxomil TabletsFailed Dissolution Specifications: low dissolution results
-
Class IIofficial
Merck & Co. Inc recalls Belsomra (suvorexant) tabletsFailed Dissolution Specifications: potential for delayed dissolution of the dose after administration which may result in delayed release of the drug, delaying onset of sleep.
-
Class IIofficial
Yangzhou Yulou Paper Products Co., Ltd recalls Quick Touch Alcohol Prep Pads(Isopropyl Alcohol 70%)cGMP Deviations
-
Class IIofficial
Aequita Pharmacy recalls Semaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj SolLack of Processing Controls.
-
Class IIofficial
Aequita Pharmacy recalls Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj SolLack of Processing Controls.
-
Class IIofficial
Aequita Pharmacy recalls Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj SolLack of Processing Controls.
-
Class IIofficial
Aequita Pharmacy recalls Tirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj SolLack of Processing Controls.
-
Class IIofficial
Aequita Pharmacy recalls Tirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj SolLack of Processing Controls.
-
Class IIofficial
Aequita Pharmacy recalls Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj SolLack of Processing Controls.
-
Class IIofficial
Aequita Pharmacy recalls Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj SolLack of Processing Controls.
-
Class IIofficial
Aequita Pharmacy recalls Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj SolLack of Processing Controls.
-
Class IIofficial
Aequita Pharmacy recalls Semaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj SolLack of Processing Controls.
-
Class IIofficial
Aequita Pharmacy recalls Semaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj SolLack of Processing Controls.
-
Class IIofficial
Aequita Pharmacy recalls Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj SolLack of Processing Controls.
-
Class IIofficial
Aequita Pharmacy recalls Semaglutide + Cyanocobalamin injection solutionLack of Processing Controls.
-
Class IIofficial
Aequita Pharmacy recalls Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj SolLack of Processing Controls.
-
Class Iofficial
DermaRite Industries, LLC recalls DermaKleenMicrobial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.
-
Class Iofficial
DermaRite Industries, LLC recalls DermaSarraMicrobial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.
-
Class Iofficial
DermaRite Industries, LLC recalls KleenFoamMicrobial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.
-
Class Iofficial
DermaRite Industries, LLC recalls PeriGieneMicrobial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.
-
Class IIofficial
Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above safety assessment limit
-
Class IIofficial
Nostrum Laboratories, Inc. recalls Sucralfate TabletsCGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.
-
Class IIofficial
Pfizer Inc. recalls Bicillin L-A (penicllin G benzathine injectable suspension)CGMP Deviations; particulates identified during visual inspection
-
Class IIofficial
Pfizer Inc. recalls Bicillin L-A (penicillin G benzathine injectable suspension)CGMP Deviations; particulates identified during visual inspection
-
Class IIofficial
A.P. Deauville, LLC recalls Power Stick for her PH Balanced Roll-On Antiperspirant Deodorant with Powder Fresh ScentCGMP Deviations
-
Class IIofficial
A.P. Deauville, LLC recalls Beauty & Skincare Power Stick original nourishing invisible protection roll-on Antiperspirant/Deodorant SpringCGMP Deviations
-
Class IIofficial
A.P. Deauville, LLC recalls Shave and Skincare Power Stick Original Nourishing Invisible Protection Roll-On Antiperspirant/DeodorantCGMP Deviations
-
Class IIofficial
Ascend Laboratories, LLC recalls Rizatriptan Benzoate TabletsCGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.
-
Class IIofficial
Ascend Laboratories, LLC recalls Rizatriptan Benzoate TabletsCGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.
-
Class IIofficial
Imprimis NJOF, LLC recalls Epinephrine Lidocaine HCLSub-Potent Drug: Subpotent assay results during stability testing.